PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
8 May 2019
KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases
Dr Marina Garassino - National Tumor Institute, Milan, Italy
15 Apr 2019
Immune checkpoint inhibitor combination efficacious for patients with high-grade...
Prof Sandip Patel - UC San Diego, San Diego, USA
11 Apr 2019
Sequencing Sorafenib and Regorafenib in advanced hepatocellular carcinoma – Brou...
Prof Josep Llovet, Dr Richard Finn
25 Feb 2019
Pan-cancer assessment of BRCA1/2 genomic alterations by comprehensive genomic pr...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, Utah
25 Oct 2018
Two important pancreatic studies: PRODIGE 24 and PREOPANC
Dr Kenneth Yu - Memorial Sloan Kettering Cancer Center, New York, USA
7 Aug 2018
MyPathway study: a novel precision oncology multiple basket trial
Dr Mary S. Beattie - Genentech, USA
6 Jul 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
4 Jul 2018
ASCO 2018 conference round up
Dr Bishal Gyawali and Will Davies
24 Jun 2018
Pancreatic survival improved with trial chemotherapy regimen after surgery
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
4 Jun 2018
Comment: Pancreatic cancer survival extended by over a year with chemotherapy re...
Dr Andrew Epstein and Prof Richard Schilsky
4 Jun 2018
Pancreatic cancer survival extended by over a year with chemotherapy regimen
Dr Thierry Conroy - Institute Cancer De Lorraine, Nancy, France
4 Jun 2018
